A carregar...
Anti‐TNF antibody treatment improves glucocorticoid induced insulin‐like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3
BACKGROUND: Insulin‐like growth factor 1 (IGF1) is an important determinant of muscle mass because it promotes growth and suppresses protein degradation. IGF1 is decreased in rheumatoid arthritis and juvenile idiopathic arthritis because its synthesis is inhibited by inflammation. In parallel, gluco...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1798065/ https://ncbi.nlm.nih.gov/pubmed/16079165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2005.040816 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|